Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Levo gets FDA fast track status for LV-101 in Prader-Willi syndrome US biotech company Levo Therapeutics has been granted fast track designation for LV-101 (intranasal carbetocin) from the US… bypharmanewsdailyNovember 19, 2019